-- Netflix (NFLX) 第一季度业绩同比增长，但这家流媒体巨头对第二季度的预期低于华尔街的预期。 每股收益从去年同期的 0.66 美元增至 1.23 美元。营收增长 16% 至 122.5 亿美元，高于 FactSet 预测的 121.8 亿美元。 Netflix 在致股东的信中表示，会员增长强于预期、价格上涨以及广告收入增加共同推动了营收增长。 Wedbush Securities 此前预计这家流媒体巨头的营收将超出预期，并表示最新一轮的价格上涨可能会提振 Netflix 今年的盈利能力。 上个月，该公司提高了其在美国的所有套餐价格，包括将广告支持的标准套餐价格提高至每月 8.99 美元。 Netflix预计第二季度营收同比增长13.5%至125.7亿美元，低于分析师预期的126.4亿美元。每股收益预计为0.78美元，低于市场普遍预期的0.84美元。 Netflix预计本季度营业利润率将从去年同期的34.1%降至32.6%。 盘后交易中，Netflix股价下跌8%。 该公司表示：“正如我们在上季度信函中所述，由于新片上线时间的影响，内容摊销的增长将主要集中在上半年。我们预计（第二季度）将实现2026年以来最高的同比增长率，之后增速将在下半年放缓至中高个位数。” Netflix 预计 2026 年营收将在 507 亿美元至 517 亿美元之间，年增长率为 12% 至 14%。市场普遍预期为 513.7 亿美元。 上周，Wedbush 将 Netflix 的目标股价从 115 美元上调至 118 美元，理由是广告收入的显著增长将推动 2026 年营收增长。 Wedbush 分析师 Alicia Reese 在周五发布的报告中写道：“Netflix 应该能够通过拓展合作伙伴关系、改进定向投放、利用人工智能以及增加更多直播内容，继续从广告业务中逐步获益。” Netflix 表示，其联合创始人兼董事长 Reed Hastings 将不会在 6 月份任期届满后竞选连任。
Related Articles
Research
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
$HIG
Research
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
$BKR
Research
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.
$WAB